Viridian Therapeutics stock popped Monday after the biotech company scored a win in thyroid eye disease, a condition that causes the eyes to swell. Please watch the video at Investors.com - How To ...
WALTHAM, Mass.--(BUSINESS WIRE)--Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biopharmaceutical company focused on discovering, developing, and commercializing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback